Spirax Group plc SPX.L
Composite 52/100; the shares have moved about 31% annualised. Names that move more contribute more risk for the same amount invested, and our composite reflects how strong the evidence for this one is right now.
Growth ranks 29/100 — a moderate mark against it.
Income ranks 70/100 — a moderate point in its favour. Quality ranks 66/100 — a moderate point in its favour. Balance-sheet strength ranks 61/100 — a slight point in its favour.
Growth ranks 29/100 — a moderate mark against it. Momentum ranks 42/100 — a slight mark against it. Valuation ranks 46/100 — a slight mark against it.
What the company does Spirax Group plc designs and manufactures thermal energy and fluid technology solutions across steam, electric, and peristaltic pump systems. Its products serve food and beverage, pharmaceuticals, oil and gas, and other industrial end-markets globally.
Key financials The group posts strong profitability with ROE 13.5%, ROCE 28.7%, and net margin 9.6%. Revenue grew 5.1% while EPS grew 0.8%, supported by high gross margins of 76.5%. Debt/equity is 0.84 with interest coverage of 6.02x and a current ratio of 1.85.
Stock health Quality pillar scores 71.5/100, but growth (40.1) and momentum (42.5) lag. The stock is down 13.96% from its 52-week high with 12-month momentum at 11.81%. Dividend yield is 2.4% with a payout ratio of 75.2%.
Price vs fair value The stock trades at a PREMIUM of 45.30% versus our fair-value estimate of 3790.66 and at a discount of 17.24% versus the analyst 12-month target of 8118.82. - Forward P/E of 21.32 vs trailing 31.40 (Valuation) - PEG of 0.45 signals undervaluation versus peers (Valuation) - Sideravia Valuation percentile 40.3/100 indicates rich pricing (Sideravia) - ROCE 28.7% supports premium valuation (Profitability) - 12-month momentum of 11.81% lags price performance (Momentum)
Looking forward Forward earnings multiple of 21.32x and PEG of 0.45 suggest potential upside if growth accelerates. Execution on margin expansion and capital allocation will be key to closing the valuation gap.
This is not investment advice. Sideravia provides automated, data-driven analysis for information and education only. Nothing on this page is a personal recommendation or an invitation to buy or sell any security, and it does not consider your objectives or financial situation. Assessments are generated by rules applied uniformly to every covered stock — how our scores work.
Data as of 2026-09-04, compiled from third-party sources; errors and delays are possible and figures are not warranted. Investing puts your capital at risk; past performance does not predict future results. We publish our full track record, including the calls that lost, and our conflicts of interest.